---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-053828"
form_type: "8-K"
ticker: "LGVN"
cik: "0001721484"
company_name: "Longeveron Inc."
filed_at: "2024-06-18T23:59:59+00:00"
generated_at: "2026-06-01T03:55:54.213116+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Longeveron raises $4.4M from warrant exercise, issues new warrants to fund Lomecel-B development

## Summary
- Gross proceeds of $4.4M from exercise of 1,697,891 existing warrants at $2.35/share.
- Issued new unregistered warrants to purchase up to 3,395,782 shares at $2.50, 24-month term.
- Proceeds for Lomecel-B development (HLHS, Alzheimer's) and general corporate purposes.
- H.C. Wainwright acted as exclusive placement agent; fees include 7% cash fee and warrants.
- Closing occurred June 18, 2024.

## SEC filing metadata
- accession: 0001213900-24-053828
- form_type: 8-K
- ticker: LGVN
- cik: 0001721484
- company_name: Longeveron Inc.
- filed_at: 2024-06-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1721484/000121390024053828/0001213900-24-053828-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1721484/000121390024053828/ea0208028-8k_longeve.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-053828
- JSON: https://secwatch.observer/filing/0001213900-24-053828.json
- Plain text: https://secwatch.observer/filing/0001213900-24-053828.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.